Literature DB >> 27020258

Thyroid function: Thyroid dysfunction and breast cancer risk - an unfinished story.

Layal Chaker1, Theo J Visser2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27020258     DOI： 10.1038/nrendo.2016.48

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

Review 1.  The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis.

Authors:  Sarah M Nielsen; Michael G White; Susan Hong; Briseis Aschebrook-Kilfoy; Edwin L Kaplan; Peter Angelos; Swati A Kulkarni; Olufunmilayo I Olopade; Raymon H Grogan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

2.  Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study.

Authors:  Mette Søgaard; Dóra Körmendiné Farkas; Vera Ehrenstein; Jens Otto Lunde Jørgensen; Olaf M Dekkers; Henrik Toft Sørensen
Journal:  Eur J Endocrinol       Date:  2016-04       Impact factor: 6.664

3.  Hypothyroidism might be related to breast cancer in post-menopausal women.

Authors:  Johannes L P Kuijpens; Ivan Nyklíctek; Marieke W J Louwman; Tony A P Weetman; Victor J M Pop; Jan-Willem W Coebergh
Journal:  Thyroid       Date:  2005-11       Impact factor: 6.568

Review 4.  Mechanisms of nongenomic actions of thyroid hormone.

Authors:  Paul J Davis; Jack L Leonard; Faith B Davis
Journal:  Front Neuroendocrinol       Date:  2007-10-05       Impact factor: 8.606

Review 5.  Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective.

Authors:  Lars C Moeller; Dagmar Führer
Journal:  Endocr Relat Cancer       Date:  2013-03-22       Impact factor: 5.678

Review 6.  Thyroid receptor: roles in cancer.

Authors:  Ana Aranda; Olaia Martínez-Iglesias; Lidia Ruiz-Llorente; Verónica García-Carpizo; Alberto Zambrano
Journal:  Trends Endocrinol Metab       Date:  2009-08-26       Impact factor: 12.015

7.  Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study.

Authors:  Peter N Taylor; Ahmed Iqbal; Caroline Minassian; Adrian Sayers; Mohd S Draman; Rosemary Greenwood; William Hamilton; Onyebuchi Okosieme; Vijay Panicker; Sara L Thomas; Colin Dayan
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

8.  Thyroid function and cancer risk: a prospective population study.

Authors:  Alf Inge Hellevik; Bjørn Olav Asvold; Trine Bjøro; Pål R Romundstad; Tom Ivar L Nilsen; Lars J Vatten
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01-20       Impact factor: 4.254

9.  Effects of thyroid hormones on human breast cancer cell proliferation.

Authors:  Linda C Hall; Eddie P Salazar; Staci R Kane; Nan Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2007-12-07       Impact factor: 4.292

Review 10.  Type 3 deiodinase and solid tumors: an intriguing pair.

Authors:  Monica Dentice; Dario Antonini; Domenico Salvatore
Journal:  Expert Opin Ther Targets       Date:  2013-08-30       Impact factor: 6.902
  10 in total
  3 in total

1.  Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer.

Authors:  Kefeng Lei; Xujun He; Leibo Yu; Chao Ni; Hailong Chen; Dandan Guan; Kewang Sun; Hai Zou
Journal:  PLoS One       Date:  2019-05-01       Impact factor: 3.240

2.  Investigating the association of rs2910164 with cancer predisposition in an Irish cohort.

Authors:  T P McVeigh; R J Mulligan; U M McVeigh; P W Owens; N Miller; M Bell; F Sebag; C Guerin; D S Quill; J B Weidhaas; M J Kerin; A J Lowery
Journal:  Endocr Connect       Date:  2017-09-12       Impact factor: 3.335

3.  Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors.

Authors:  Haomin Yang; Natalie Holowko; Felix Grassmann; Mikael Eriksson; Per Hall; Kamila Czene
Journal:  BMC Med       Date:  2020-08-25       Impact factor: 8.775
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.